These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34128764)

  • 21. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Marcus R; Salles G; Vitolo U; Ladetto M;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii76-82. PubMed ID: 25122695
    [No Abstract]   [Full Text] [Related]  

  • 23. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v181-3. PubMed ID: 20555076
    [No Abstract]   [Full Text] [Related]  

  • 24. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Rule S; Salles G; Ladetto M; Tonino SH; Herfarth K; Seymour JF; Jerkeman M;
    Ann Oncol; 2021 Mar; 32(3):298-308. PubMed ID: 33249059
    [No Abstract]   [Full Text] [Related]  

  • 25. Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework.
    Glasgow RE; Gurfinkel D; Waxmonsky J; Rementer J; Ritchie ND; Dailey-Vail J; Hosokawa P; Dickinson LM; Kwan BM
    BMC Health Serv Res; 2021 Oct; 21(1):1039. PubMed ID: 34598702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
    Loudon K; Zwarenstein M; Sullivan F; Donnan P; Treweek S
    Trials; 2013 Apr; 14():115. PubMed ID: 23782862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pragmatism in Pediatric Neurosurgery: More Than a Pipe Dream? A Systematic Literature Review and Analysis.
    Kik CC; Spoor JKH
    World Neurosurg; 2022 May; 161():418-423. PubMed ID: 35505562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2008 May; 19 Suppl 2():ii77-8. PubMed ID: 18456778
    [No Abstract]   [Full Text] [Related]  

  • 29. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.
    Hiddemann W;
    Ann Oncol; 2003 Aug; 14(8):1163-4. PubMed ID: 12881368
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.
    Sweetenham JW; Goldman B; LeBlanc ML; Cook JR; Tubbs RR; Press OW; Maloney DG; Fisher RI; Rimsza LM; Braziel RM; Hsi ED
    Ann Oncol; 2010 Jun; 21(6):1196-1202. PubMed ID: 19875761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.
    Selby P; Brosky G; Oh PI; Raymond V; Ranger S
    BMC Med Res Methodol; 2012 Jul; 12():101. PubMed ID: 22824225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
    Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
    Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?
    Cheng S; McDonald EJ; Cheung MC; Arciero VS; Qureshi M; Jiang D; Ezeife D; Sabharwal M; Chambers A; Han D; Leighl N; Sabarre KA; Chan KKW
    J Clin Oncol; 2017 Aug; 35(24):2764-2771. PubMed ID: 28574778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intervention Fidelity in Pain Pragmatic Trials for Nonpharmacologic Pain Management: Nuanced Considerations for Determining PRECIS-2 Flexibility in Delivery and Adherence.
    Kerns RD; Davis AF; Fritz JM; Keefe FJ; Peduzzi P; Rhon DI; Taylor SL; Vining R; Yu Q; Zeliadt SB; George SZ
    J Pain; 2023 Apr; 24(4):568-574. PubMed ID: 36574858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic Review.
    Choi MY; Barnabe C; Barber CE; Bykerk V; Pope JE; Hazlewood GS
    Arthritis Care Res (Hoboken); 2019 May; 71(5):620-628. PubMed ID: 29908014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index.
    Gaudino M; Hameed I; Biondi-Zoccai G; Tam DY; Gerry S; Rahouma M; Khan FM; Angiolillo DJ; Benedetto U; Taggart DP; Girardi LN; Crea F; Ruel M; Fremes SE
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e006017. PubMed ID: 31822120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer.
    Koppikar S; Oaknin A; Babu KG; Lorusso D; Gupta S; Wu LY; Rajabto W; Harano K; Hong SH; Malik RA; Strebel H; Aggarwal IM; Lai CH; Dejthevaporn T; Tangjitgamol S; Cheng WF; Chay WY; Benavides D; Hashim NM; Moon YW; Yunokawa M; Anggraeni TD; Wei W; Curigliano G; Maheshwari A; Mahantshetty U; Sheshadri S; Peters S; Yoshino T; Pentheroudakis G
    ESMO Open; 2023 Feb; 8(1):100774. PubMed ID: 36696825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.